Last reviewed · How we verify
Evaluation for the Efficacy,Tolerability,and Safety of Rasagiline in Levodopa-treated PD Patients With Motor Fluctuations: A Multicenter, Double Blind, Randomized, Placebo-Controlled Group Study (China)
The objective of this study is to evaluate the efficacy, tolerability, and safety of rasagiline compared to placebo in PD patients with motor fluctuations on levodopa therapy.
Details
| Lead sponsor | Chongqing Fortune Pharmaceutical Co., Ltd. |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 268 |
| Start date | 2011-11 |
| Completion | 2013-06 |
Conditions
- Parkinson´s Disease
Interventions
- Rasagiline
- Placebo
Primary outcomes
- Efficacy of rasagiline vs placebo as assessed by the change from baseline to week 14 in mean total daily OFF time measured by patients' home diaries in levodopa-treated PD patients with motor fluctuations. — 0, 14 weeks
Countries
China